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ABSTRACT
The advent of polypharmacology paradigm in drug
discovery calls for novel chemoinformatic tools
for analyzing compounds’ multi-targeting activities.
Such tools should provide an intuitive representa-
tion of the chemical space through capturing and vi-
sualizing underlying patterns of compound similari-
ties linked to their polypharmacological effects. Most
of the existing compound-centric chemoinformatics
tools lack interactive options and user interfaces that
are critical for the real-time needs of chemical biolo-
gists carrying out compound screening experiments.
Toward that end, we introduce C-SPADE, an open-
source exploratory web-tool for interactive analysis
and visualization of drug profiling assays (biochem-
ical, cell-based or cell-free) using compound-centric
similarity clustering. C-SPADE allows the users to
visually map the chemical diversity of a screening
panel, explore investigational compounds in terms
of their similarity to the screening panel, perform
polypharmacological analyses and guide drug-target
interaction predictions. C-SPADE requires only the
raw drug profiling data as input, and it automatically
retrieves the structural information and constructs
the compound clusters in real-time, thereby reduc-
ing the time required for manual analysis in drug de-
velopment or repurposing applications. The web-tool
provides a customizable visual workspace that can
either be downloaded as figure or Newick tree file or
shared as a hyperlink with other users. C-SPADE is
freely available at http://cspade.fimm.fi/.
INTRODUCTION
Drug discovery has witnessed a paradigm shift from the
traditional one drug-one target view to the multi-target ap-
proach, creating a need for novel computational tools that
could aid in polypharmacological studies. Polypharmacol-
ogy refers to the ability of a drug molecule to interact
with multiple targets simultaneously (1,2). Such promiscu-
ous drug-target interactions may lead to both therapeutic
effects and off-target side effects. Recent efforts in drug dis-
covery have made use of polypharmacology as a means
of repurposing or repositioning approved drugs for novel
disease targets (3), which in-turn may significantly reduce
both the economic cost and time invested in drug devel-
opment process (4,5). Polypharmacology can also help to
design selectively promiscuous drugs, such as multi-kinase
anti-cancer agents (2,6). Furthermore, polypharmacology
is being used to identify and explain the off-target activities
of drugs that result in harmful side-effects, thereby assist-
ing in compound optimization applications (7). The existing
computational approaches for investigating polypharmaco-
logical effects and predicting drug-target interactions can
be broadly categorized as target-centric (8,9) or compound-
centric (10,11). The underlying hypothesis in the target-
centric approaches is that structurally similar targets are
expected to have similar selectivity properties, and hence
are likely to bind the same compound. Therefore, this ap-
proach is useful for target-based drug discovery approach,
although it is applicable only to targets whose structural
information is available. The compound or chemo-centric
approach is based on the principle that structurally similar
compounds tend to bind to the same targets; therefore, this
approach is best-suited for identifying compound analogs,
hence supporting the phenotype-based and polypharma-
cology paradigm of drug discovery.
Chemoinformatic web-applications have been developed
for target-centric visualization of broad spectrum activity
of compounds against well-studied protein families such
as kinases; e.g. Kinome Render (12), TREEspot and Kin-
Map (13). For the compound-centric analyses, similar easy-
to-use web-tools are not available, although the computa-
tional protocol to estimate compound similarities has been
detailed by Vilar et al. (14). Most of the existing tools to
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analyze drug screening assays through clustering and vi-
sualization of compounds and their corresponding bioac-
tivity measurements have been implemented as stand-alone
tools requiring local installation, e.g. Scaffold Hunter (15),
ChemTreeMap (16), Mona 2 (17) and Data warrior (18) or
as a browser-based tool, e.g. ChemMineTools (19). How-
ever, most tools assume the users to have chemoinformat-
ics and database management skills (MySQL), and either
require the structure of the compounds or their PubChem
compound identifiers as a primary input (20). Further-
more, even though the existing tools can address a broad
range of questions arising in drug discovery applications,
they often lack an interactive interface and other user op-
tions required by a chemical biologist for real-time sharing,
visualization and interpretation of bioactivity data from
drug screening assays. To address these limitations, we have
capitalized on recent developments in server management
and Data Object Model (DOM) frameworks, and imple-
mented a fully-automated, open-source web-based applica-
tion, named Compound SPecific bioActivity DEndrogram
(C-SPADE), which enables biologists with little to no infor-
matics skills to interactively visualize, annotate and inves-
tigate the relationships between the compounds’ structural
similarities and phenotypic responses through compound-
centric bioactivity clustering.
MATERIALS AND METHODS
Implementation
C-SPADE web-application adapts a client-server model
(Figure 1), in which session management is maintained
through Python Django (version 1.9), and the server-side
computation is implemented using Python (version 2.7).
The compound names in the input screening data are au-
tomatically queried against the PubChem database (21) to
retrieve structural description as SMILES. The user can
also directly upload the SMILES information of the com-
pounds, which is useful especially when multiple custom
structures are used as input. The input data is later displayed
on the Data Preview page. C-SPADE utilizes the RDKit
python module (version 2016.09.1) to calculate various
compound fingerprints (FPs) and their similarities. With
the MACCS and Daylight FPs, the structural similarity
is calculated using Tanimoto similarity (22), whereas with
Atom-pair and Morgan (ECFP-like) FPs using Dice sim-
ilarity (23) coefficient. The Scipy module (version 0.13.2)
then constructs an agglomerative hierarchical cluster using
the compound similarities, where the linkage distance be-
tween clusters are estimated using the Ward minimum vari-
ance method. The resulting compound dendrogram is an-
notated with bioactivity values and saved as a JavaScript
Object Notation (JSON) file for client input. The client-
side uses DOM implemented through D3 JavaScript library
(http://d3js.org/), HTML5 Canvas and CSS for the inter-
active analysis and visualization of the compound similar-
ity dendrogram. C-SPADE has been checked for compati-
bility with all standard modern browsers (Mozilla Firefox,
Google Chrome and Safari) and operating systems (Win-
dows, MacOSX and various Linux distributions).
Session management
C-SPADE enables the analysis of multiple inputs simulta-
neously and displays each submission in a separate row on
theMy Projects page, providing links to Data Preview page
and Visualization page as icons that are color-coded based
on the status of data processing. The link to Visualization
page is not available until the user invokes it from the Data
Preview page, which serves as a check to ensure that the
user has verified the automatically-retrieved information.
The user can either bookmark the web address or save the
workspace to enable saving and processing the results at a
later time. Each user session is managed anonymously and
has an expiration period of 10 days, providing the user suf-
ficient time to analyze the output. C-SPADE visualization
has been designed for low-throughput studies; a profiling
data of ∼500 compounds takes less than 6 min to process
and visualize. Larger datasets (>600 compounds), although
computationally more intensive and time consuming, can
still be processed, and the user can retrieve the compound
similarity dendrogram as a Newick tree file for further anal-
yses.
Input format
C-SPADE currently accepts a tab-delimited text file (.txt)
of a preprocessed drug screening data as input. The input
file should include the following columns: Compound (re-
quired), the unique names of the compounds used in the
screen; Smiles (optional), the compounds whose SMILES
information is provided will be directly used by C-SPADE
to calculate their structural features; otherwise, the com-
pound nameswill be queried against the PubChemdatabase
to retrieve the SMILES; one or more screening assays (op-
tional) (i.e. protein targets, cell lines, patient samples, etc.),
each assay in a separate column providing numerical bioac-
tivity values (e.g., IC50, EC50, Ki, Kd, area under the dose
response curve (AUC) or drug sensitivity score (DSS) (24));
Annotation (optional), additional annotations of the com-
pounds (e.g. compound class, compound properties, etc.), if
available.
Compound selection
The Data Preview page allows the user to edit, curate and
select a subset of data for visualization. Compounds whose
SMILES are either provided by user or retrieved from Pub-
Chem are automatically selected for the visualization. The
PubChem compound identifiers (CID) in the Data Preview
page are hyperlinked to the PubChem database, giving the
user the possibility to check the retrieved compound’s in-
formation. The user can visualize the chemical diversity of
a subset of compounds from the screening panel by select-
ing the compounds using the check boxes located at the be-
ginning of each row in the table (note: a minimum of 10
compounds are required to generate the clustering dendro-
gram). Through the Add Compounds option, C-SPADE fa-
cilitates on-the-fly similarity investigation, where the simi-
larity of one or more investigational molecules to the drugs
in the screening panel can be visualized. Selecting this op-
tion adds a new row in the table, where the user is expected
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Figure 1. An infographic illustration of C-SPADEweb-tool and its functionalities. (A) Various types of biological drug screening assays (biochemical, cell-
based, cell-free or target-based assays) can be analyzed. (B) The key functionalities implemented in C-SPADE. (C) The input consists of a tab-delimited
text file of drug screening data, with compound names and bioactivity values, where a wide range of activity measurements are supported. (D) On the
server-side, the compound name is used to retrieve the compound structural information from the PubChem database and various compound features are
calculated using the RDKit package. (E) The client-side options provide an interactive interface to visualize and customize the compound clusters. (F) The
output visualization from C-SPADE can be either shared with collaborators or downloaded as publication-quality images or as a Newick tree file.
to provide the name of the compound and its structural in-
formation as SMILES. These compounds can be clustered
and visualized with the selected compounds in the table us-
ing the Visualize option.
Cluster visualization
Similar to a traditional phylogenetic tree, the main visual
interface in C-SPADE displays the chemical space of com-
pounds used in the screen as a hierarchically-clustered den-
drogram, where each compound forms the node in the tree
annotated with their respective bioactivity values as bub-
bles (Figure 2A). Currently, C-SPADE uses molecular fin-
gerprints as features to measure the compound similarity;
the closer two compounds are in the tree, the higher is their
chemical similarity in terms of their similarity coefficient.
The bioactivity values from individual screens of each com-
pound are categorized into five potency classes using log-
transformed IC50, EC50, Ki, Kd values (≤1 nM, ≤10 nM,
≤100 nM, ≤1 uM, ≤10 uM) and displayed in the dendro-
gram. With the summary measurements, such as AUC and
DSS, the actual bioactivity values are used and represented
as circular annotations in the dendrogram. Visual key for
the bioactivity values, activity classes, and compound an-
notations are shown in the legend of the dendrogram to in-
terpret the output visualization (Figure 2B).
Interactive options
C-SPADE serves as an exploratory tool and provides a
highly interactive and customizable visual workspace. For
instance, the user has the options to upload multiple
datasets, and in real-time change the molecular features
for calculating the compound similarity clusters. The vi-
sual workspace that displays the compound dendrogram
provides several options in the sidebar to interactively cus-
tomize the visualization. The layout of the displayed den-
drogram can be altered between a tree and radial layout
(Figure 2C). Features corresponding to the branches and
nodes of the tree, such as thickness, radius and colors, can
also be dynamically changed. The font sizes of compound
labels and annotations are adjustable. Color coding of dif-
ferent assay classes and compound annotations can be in-
teractively changed, and these changes are simultaneously
updated in the figure legend. In addition to the traditional
zoom and pan functions, C-SPADE provides also other
toolbar options, such as a search bar to search and high-
light a compound in the tree and rotate option to rotate a
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Figure 2. (A) Compound-centric bioactivity dendrogram visualization of the example drug screening data (25). The drug panel contained a total of 250
compounds screened across three cytarabine-resistant SHI-1 cell-line variants (Parental, 320Ara-C and 1280Ara-C) to identify drugs that could counteract
cytarabine resistance. A subset of 75 compounds were selected and their chemical space was visualized using the C-SPADE web-tool. The nodes are the
compounds and the distance between the nodes represents the degree of their structural similarity based on the selected ECFP4 fingerprints. The bioactivity
measurements (DSS) of each compound are represented as circles, where the radius of the circle is proportional to the bioactivity level. Inset: the distinct
sub-clusters of glucocorticoids (d) and nucleoside analogues (e). (B) The provided bioactivities, activity classes and compound annotations, if available, are
color-coded and displayed in the legend. (C) The types of dendrogram layouts and styles that are currently available in C-SPADE. The glucocorticoids (D)
showed an increased sensitivity in the cytarabine resistant cell-lines, whereas the nucleoside analogues (E) showed a co-resistance pattern in the cytarabine
resistant SHI-1 cells. In this example, C-SPADE enables the user to (i) map the chemical space of the compounds screened, (ii) explain the sub-clustering
patterns that one commonly encounters in such drug-screening data analysis, and (iii) investigate and predict structurally similar compounds that cluster
into a desired activity cluster prior to a future compound screening application.
radial tree to any given angle. Hovering the mouse pointer
over a bioactivity bubble or a compound name displays a
tooltip that shows the input bioactivity value or structure
of the compound, respectively. The Save Workspace option
saves the last performed changes by the user in the visual
workspace, hence providing themost updated version of the
visualization when revisited.
Output formats
Once customized, the compound clustering can be down-
loaded either as Portable Network Graphics image (.png)
or as a Portable Document Format file (.pdf). The web-tool
enables background transparency and maintains a high de-
gree of spatial resolution for these outputs files, thereby gen-
erating publication-ready figures. The user can also choose
to download the compound similarity dendrogram in a
Newick file format (.nwk) to post-process the hierarchi-
cal tree object independent of the C-SPADE. By using the
Share option, the user can share the hyperlink to the visual
workspace, providing the possibility for collaborators to vi-
sualize and customize the results interactively.
Documentation and example data
To enable easy start, we have provided an extensive docu-
mentation in the help section that explains all the features
of C-SPADE in detail. For testing the web-tool we also pro-
vide an example data in the form a preprocessed subset of
bioactivity data from a cell-based drug screening assay by
Malani et al. (25). This example dataset contains 75 com-
pounds screened across three cell-types (Figure 2A), using
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DSS as the bioactivity measure, and with a subset of com-
pounds annotated by the inhibitor type (Figure 2D and E)
(e.g. glucocorticoids (Figure 2D), nucleoside analogue (Fig-
ure 2E), anti-metabolite, etc.). For templates of the input
data, the user can download this example data in various
formats. We have also implemented a quick tutorial section
to help the users to quickly go through C-SPADE’s func-
tionalities (available at http://cspade.fimm.fi/).
CONCLUSION AND FUTURE WORK
We have implemented C-SPADE, a secure web-based ap-
plication that enables the users to interactively map and
explore drug screening data. Through constructing and vi-
sualizing compound-specific dendrograms, C-SPADE, pro-
vides a timely solution to the critical need for an efficient
and easy-to-use compound-centric visualization tool, hence
facilitating chemical biology researchers in various pheno-
typic screening and polypharmacology-based drug discov-
ery applications. By merely requiring the compound names
(and no structural information), C-SPADE serves as a one
click tool, thereby significantly reducing the time needed
fromdrug screening to data analysis and interpretation. The
web-tool was designed mainly for the needs of biologist;
to understand the diversity of the screening panel, to ex-
plore investigational compounds’ similarity to the screen-
ing panel, and for polypharmacological explorations. How-
ever, C-SPADEmay also aid chemo-informaticians to draw
conclusions related to drug-target interaction predictions.
When comparedwith the traditional heat-map visualization
of drug screening data, C-SPADE, through its compound-
specific clustering, provides a novel perspective to analyze
drug screening data.
Like any other browser-based application, C-SPADE is
limited by the size of the data that can be processed and
visualized. The current version of C-SPADE uses standard
fingerprint measurements from SMILES as compound fea-
tures, and one future improvementwill be to incorporate 2D
and 3D molecular descriptor information in feature calcu-
lation. The next version of C-SPADE will incorporate also
sub-cluster analysis and implement the Maximum Com-
mon Substructure (26) algorithm to aid users in compound-
optimization studies.
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